Eton Pharmaceuticals, Inc. - COM (ETON)

Historical Portfolio Holders from Q4 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
9.51M
Holdings value Q3 2024
$57M
Value change Q3 2024
+$8.31M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
47
Number of buys Q3 2024
23
Number of sells Q3 2024
-16
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 9.51M $57M +$8.31M $6.00 48
2024 Q2 8.23M $27.1M +$3.4M $3.29 44
2024 Q1 7.18M $26.9M -$87.3K $3.75 43
2023 Q4 7.16M $31.4M +$1.22M $4.38 55
2023 Q3 6.9M $28.8M +$3.93M $4.17 52
2023 Q2 5.98M $20.9M +$425K $3.49 33
2023 Q1 5.84M $22.5M +$148K $3.85 34
2022 Q4 5.94M $18.2M -$814K $2.82 32
2022 Q3 6.34M $13.3M +$814K $2.10 29
2022 Q2 5.92M $17.7M +$787K $2.62 29
2022 Q1 5.78M $27.4M +$1.31M $4.36 31
2021 Q4 5.73M $24.6M -$1.09M $4.29 30
2021 Q3 5.96M $32.6M -$1.72M $5.04 35
2021 Q2 3.15M $22.5M -$10.3M $6.16 43
2021 Q1 8.79M $68M +$531K $7.32 49
2020 Q4 8.73M $75M +$13.8M $8.13 45
2020 Q3 7.03M $59.5M +$2.21M $7.90 38
2020 Q2 6.8M $39.8M +$5.74M $5.45 40
2020 Q1 5.97M $24.5M +$13.4M $4.10 17
2019 Q4 2.62M $18.9M +$2.67M $7.20 13
2019 Q3 2.28M $14.4M +$3.22M $6.31 14
2019 Q2 1.77M $14M +$2.1M $7.90 10
2019 Q1 1.5M $12M +$2.81M $8.00 12
2018 Q4 1.15M $7.05M +$7.05M $6.12 11